Jonathan Smith

Latest from Jonathan Smith

Sean Knight, Senior Director, Business Development, Simtra BioPharma Solutions, discusses the company’s expansion plans.
Outsourcing
Going to Market with Simtra BioPharma SolutionsGoing to Market with Simtra BioPharma Solutions
byBIO-Europe 2024
Dec 19, 2024
3 Min View
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep TechRESEAU SATT, the Best of French Deep Tech
byBIO-Europe 2024
Dec 18, 2024
3 Min View

All from Jonathan Smith

Janet Hoogstraate, CEO, NorthX Biologics discusses the CDMOs capabilities and expertise.
Outsourcing
NorthX Biologics is Beyond CDMO
NorthX Biologics is Beyond CDMO
Dec 18, 2024
|
4 Min View
byBIO-Europe 2024
Simon Fagg, Founder of coaching and training organization With Leadership
Best Practices
Tips Toward a Better Presentation
Tips Toward a Better Presentation
Dec 18, 2024
|
3 Min View
byBIO-Europe 2024
Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss commercial readiness of biotechs
Scaling/Commercialization
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Dec 18, 2024
|
9 Min View
byBIO-Europe 2024
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Dec 18, 2024
|
8 Min View
byBIO-Europe 2024
2024 on a road
Investment
Megadeals continued amid sluggish investments and M&A in 2024
Megadeals continued amid sluggish investments and M&A in 2024
Dec 18, 2024
|
2 Min Read
byJonathan Smith
Walter Boyle, Global Head of Axio, Cytel Inc., BIO-Europe 2024
Outsourcing
Why are DMCs Important to Clinical Development?
Why are DMCs Important to Clinical Development?
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024
@Informa BIO-Europe 2024, CEO of Cellevate interview
Scaling/Commercialization
Scale Up and Boost Your Viral Vector Production
Scale Up and Boost Your Viral Vector Production
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

News from APAC

Asia currency
Investment
Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia assetEyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset
byRichard Daverman
Dec 17, 2024
6 Min Read
China on a clock
Investment
A growing phenomenon: The rise of biopharma NewCos in ChinaA growing phenomenon: The rise of biopharma NewCos in China
byRichard Daverman
Dec 13, 2024
7 Min Read
Currency
Investment
Eyes on Asia: Merck and BioNTech land Chinese bispecificsEyes on Asia: Merck and BioNTech land Chinese bispecifics
byRichard Daverman
Dec 4, 2024
4 Min Read
Jan 13 - Jan 15, 2025
An all-inclusive healthcare conference at Hilton Union Square, San Francisco
Register

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated